You are here

Article Text

Article menu
Download PDFPDF
Miscellanea
Journal club
Fibulin-3 as a blood and effusion biomarker for pleural mesothelioma
  1. James Murray
  1. Correspondence to Dr James Murray, ST3, Department of Respiratory Medicine, King George Hospital, Barley Lane, Ilford, London IG3 8YB, UK; jamesmurray{at}doctors.org.uk

https://doi.org/10.1136/thoraxjnl-2013-203396

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    This study investigated whether plasma and pleural effusion levels of fibulin-3 (an extracellular glycoprotein found to be expressed by mesothelioma cells) could be used to differentiate pleural mesothelioma from other pleural effects of asbestos exposure; benign pleural effusions, pleural effusions from other malignancy and healthy controls. Previously identified biomarkers have shown …

    View Full Text